Moderna

Moderna Inc. Chief Financial Officer Jorge Gomez departed a day after taking charge, the vaccine maker said on May 11, following his former employer disclosing an internal probe related to financial reporting.

Bruised and battered by its failings with the controversial Alzheimer’s drug Aduhelm, Biogen is looking to right the ship with a new helmsman. The company is on the hunt for a new chief executive officer. 

Zymeworks provided a corporate update that included a string of clinical trial news. Additionally, 10 members of Zymeworks’ senior management team are leaving the clinical-stage biopharmaceutical company and the employee headcount will be cut by at least 25 percent by the end of 2022.

Hal Barron, who guided the reinvigoration of the pharmaceutical direction at GlaxoSmithKline, is departing the company as GSK undergoes a planned demerger later during 2022.

Fully integrated biopharmaceutical solutions organization Syneos Health announced the appointment of two new independent directors, Barbara W. Bodem and Alfonso G. Zulueta, to its Board of Directors.

After serving three presidential administrations, Dr. Francis S. Collins is stepping down as director of the National Institutes of Health at the end of 2021 with a successor yet to be named.

A pair of the U.S. Food and Drug Administration’s top vaccine experts are leaving the regulatory agency.

GlaxoSmithKline discontinued a Phase II clinical trial evaluating an anti-LAG3 cell depleting monoclonal antibody aimed at treating ulcerative colitis licensed from Australia-based Immutep Limited following an interim assessment of an Independent Data Monitoring Committee.

Moncef Slaoui, the GlaxoSmithKline vaccines veteran who has helmed the federal government’s Operation Warp Speed Covid-19 vaccine program, is stepping down from the role ahead of the inauguration of President-elect Joe Biden.

Med Ad News talked to Sharon Callahan, the new CEO of CDM, and Robin Shapiro, who moved into the position of CEO of TBWA\WorldHealth, about changes at their agencies and what it’s like taking on new roles at a time when COVID-19 has literally changed everything about the way that everyone works.